{"relation": [["", "STARTED", "COMPLETED", "NOT COMPLETED", "Death", "Not able to get to clinic"], ["LPV/r Monotherapy", "122", "117", "5", "3", "2"]], "pageTitle": "Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy - Study Results - ClinicalTrials.gov", "title": "", "url": "https://clinicaltrials.gov/ct2/show/results/NCT00357552?sect=X01&view=results", "hasHeader": true, "headerPosition": "FIRST_ROW", "tableType": "RELATION", "tableNum": 8, "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042992201.62/warc/CC-MAIN-20150728002312-00149-ip-10-236-191-2.ec2.internal.warc.gz", "recordEndOffset": 851305527, "recordOffset": 851289133, "tableOrientation": "HORIZONTAL", "textBeforeTable": "Period 1: \u00a0 Screening Participant Flow for 3 periods Participants will receive lopinavir/ritonavir twice daily for up to 104 weeks. Upon confirmation of virologic failure, emtricitabine (FTC)/tenofovir (TDF) once a day will be added to their regimen. LPV/r Monotherapy Description \u00a0 Reporting Groups No text entered. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details No text entered. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow Drug: Emtricitabine/Tenofovir disoproxil fumarate Drug: Lopinavir/Ritonavir Interventions:", "textAfterTable": "[1] The number of participants who started this period, is the number of participants who screened. [2] The number of participants who completed this period, is the number of participants who enrolled. Period 2: \u00a0 Weeks 0 to 24 \u00a0 \u00a0 LPV/r Monotherapy \u00a0 STARTED \u00a0 \u00a0 123 \u00a0 COMPLETED \u00a0 \u00a0 122 [1] NOT COMPLETED \u00a0 \u00a0 1 \u00a0 Death \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0 [1] One subject died prior to week 24. Period 3: \u00a0 Weeks 24 to 104 \u00a0 \u00a0 LPV/r Monotherapy \u00a0 STARTED", "hasKeyColumn": true, "keyColumnIndex": 0, "headerRowIndex": 0}